Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Esomeprazole (Primary)
- Indications Reflux oesophagitis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 30 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2014 Planned End Date changed from 1 Apr 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.